PSMA-IN-3 [CAS 2941187-68-2]

PSMA-IN-3 (compound 17) is a novel high-affinity PSMA inhibitor with an IC50 value of 13 nM. PSMA-IN-3 is suitable for developing an 18F-labeled radioligand for PET imaging of PSMA in prostate cancer[1].

[2941187-68-2]

C43H50FN7O15

923.89

FC1=CC=C(C=C1)/C=N/OCC(NCC(N[C@H](C(O)=O)CC2=CC=C(C=C2)OCC(N[C@H](C(NCCCC[C@H](NC(N[C@H](C(O)=O)CCC(O)=O)=O)C(O)=O)=O)CC3=CC=CC=C3)=O)=O)=O

PSMA

10 mM in DMSO

Room temperature